Proteome analysis of Pueraria mirifica tubers collected in different seasons. Jungsukcharoen J, Chokchaichamnankit D, Srisomsap C, Cherdshewasart W, Sangvanich P*. Biosci Biotechnol Biochem. 2016 Jun;80(6):1070-80.

01 Jun 2016
0
0

Proteome analysis of Pueraria mirifica tubers collected in different seasons.

Jungsukcharoen J, Chokchaichamnankit D, Srisomsap C, Cherdshewasart W, Sangvanich P*.

Biosci Biotechnol Biochem. 2016 Jun;80(6):1070-80.

Tags

Share this

Related Posts

Effects of topical exposure to a mixture of chlorpyrifos, cypermethrin and captan on the hematological and immunological systems in male Wistar rats. Aroonvilairat S, Tangjarukij C, Sornprachum T, Chaisuriya P, Siwadune T, Ratanabanangkoon K. Environ Toxicol Pharmacol. 2018 Apr;59:53-60. doi: 10.1016/j.etap.2018.02.010. Epub 2018 Mar 2.
01 Apr 2018
0

Effects of topical exposure to a mixture of chlorpyrifos, cypermethrin and captan on the hematological and immunological systems in male Wistar rats. Aroonvilairat S, Tangjarukij C, Sornprachum T, Chaisuriya P, Siwadune T, Ratanabanangkoon K. Environ Toxicol Pharmacol. 2018 Apr;59:53-60. doi: 10.1016/j.etap.2018.02.010. Epub 2018 Mar 2.

Effects of topical exposure to a mixture of chlorpyrifos, cypermethrin and captan on the hematological and immunological systems in male Wistar rats. Aroonvilairat S, Tangjarukij C, Sornprachum T, Chaisuriya P, Siwadune T, Ratanabanangkoon K. Environ Toxicol Pharmacol. 2018 Apr;59:53-60. doi: 10.1016/j.etap.2018.02.010. Epub 2018 Mar 2.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New
20 Sep 2023
0
New

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More